Taizhou, China

Jianqiang Qian

This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang Jiuzhou Pharmaceutical Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianqiang Qian. Retrieved from https://idiyas.com/inventor/jianqiang-qian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jianqiang Qian: Innovator in Pharmaceutical Synthesis

Introduction

Jianqiang Qian is a notable inventor based in Taizhou, China. He has made significant contributions to the field of medicine and organic synthesis. His work primarily focuses on innovative methods for drug preparation.

Latest Patents

Jianqiang Qian holds a patent for a method of preparing crizotinib. This invention relates to the technical field of medicine and organic synthesis. The method involves a Suzuki coupling reaction between specific compounds to produce crizotinib, which is then subjected to deprotection.

Career Highlights

He is currently associated with Zhejiang Jiuzhou Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing methods for drug synthesis.

Collaborations

Some of his notable coworkers include Yuanqiang Li and Daqing Che, who contribute to the collaborative efforts in their research and development projects.

Conclusion

Jianqiang Qian's innovative approach to pharmaceutical synthesis exemplifies the impact of dedicated inventors in the medical field. His contributions continue to influence advancements in drug preparation methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…